Aaron Tallent
Freelance Writer and Editor at Freelance
Writer with more than 20 years in communication fields including journalism, media advocacy, health, and sports history. Co-host of the @LoadedGoatPod.
Articles
-
1 week ago |
oncologynewscentral.com | Aaron Tallent
Two studies published last month highlight the feasibility and challenges associated with implementing electronic patient-reported outcome (ePRO) systems in community oncology. The first, published in JCO Oncology Practice, breaks down semistructured interviews with providers, clinic staff, and patients receiving treatment for metastatic cancer in community oncology practices that implemented ePRO systems as part of the national PRO-TECT trial.
-
1 week ago |
oncologynewscentral.com | Aaron Tallent
Patients with cancer are increasingly using cannabis to help manage symptoms of their disease and adverse effects from treatment. That uptake is happening so rapidly that many oncologists are struggling to keep up with the latest information on how best to guide them. Experts in integrative oncology discussed the latest guidance at the Community Oncology Alliance’s (COA’s) 2025 Community Oncology Conference.
-
1 week ago |
oncologynewscentral.com | Aaron Tallent
Although more and more lawmakers in Congress are becoming educated on how the practices of pharmacy benefit managers (PBMs) affect patient care, legislative successes to address them are coming at the state level. At the Community Oncology Alliance’s (COA’s) 2025 Community Oncology Conference, policy experts discussed three laws in Arkansas that could guide broader future PBM reform efforts.
-
1 week ago |
oncologynewscentral.com | Aaron Tallent
The Inflation Reduction Act (IRA) passed in 2022 gives Medicare the authority to directly negotiate with drug companies on the price of the costliest brand name Medicare Part B and Part D drugs. Although this was intended to improve access for patients, cancer care experts warn that it could do the exact opposite and force practices to close. These concerns were discussed during a session at the Community Oncology Alliance’s (COA’s) 2025 Community Oncology Conference.
-
1 week ago |
idse.net | Aaron Tallent
Histoplasmosis is a common fungal infection found in river valley areas, but its severity can vary between no symptoms and death if untreated. To help guide physicians in knowing when to take action or not, the Infectious Diseases Society of America (IDSA) has issued four updated recommendations to its guideline that cover the treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas), mild acute pulmonary histoplasmosis and moderate acute pulmonary histoplasmosis.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 6K
- DMs Open
- No
Payer contract negotiations in #Oncology are all about relationships, timing, and data. 🤝 From term notices tousing deprivation scores for public-health insights, practice leaders at #COA2025 discuss their approach. #CancerCare https://t.co/KSZl4soPuW
Clinical trials are booming—2,000 new trials/year (+11% since 2019)—yet access at community oncology practices remains flat. 🚀 Success drivers? Physician champions, dedicated trial staff, and site management organizations! #COA2025 #CancerResearch https://t.co/yciF0PFkea
The upcoming #COA2025 Community Oncology Conference will include sessions on Medicare drug-price negotiations, leadership & team culture, and the future of AI in oncology workflows. #CommunityOncology #CancerCare https://t.co/c8klUB6QiO